Xie; Rongyuan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xie; Rongyuan.The latest application filed is for "substituted imidazole derivatives and methods of use thereof".

Company Profile

1.12.18

Xie; Rongyuan - Greensboro NC
Xie; Rongyuan - High Point NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted imidazole derivatives and methods of use thereof Grant 10,363,241 - Jones , et al.	2019-07-30
Substituted Imidazole Derivatives and Methods of Use Thereof App 20190076402 - Jones; David ; et al.	2019-03-14
Substituted Imidazole Derivatives and Methods of Use Thereof App 20170157093 - Jones; David ; et al.	2017-06-08
Phenyl-heteroaryl derivatives and methods of use thereof Grant 9,045,461 - Gohimukkula , et al. June 2, 2	2015-06-02
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof App 20140206660 - Gohimukkula; Devi R. ; et al.	2014-07-24
Phenyl-heteroaryl derivatives and methods of use thereof Grant 8,741,900 - Gohimukkula , et al. June 3, 2	2014-06-03
Substituted Imidazole Derivatives and Methods of Use Thereof App 20140039025 - Jones; David ; et al.	2014-02-06
Substituted imidazole derivatives and methods of use thereof Grant 8,580,833 - Jones , et al. November 12, 2	2013-11-12
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors Grant 8,450,354 - Mjalli , et al. May 28, 2	2013-05-28
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors Grant 8,404,731 - Mjalli , et al. March 26, 2	2013-03-26
Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors Grant 8,350,039 - Mjalli , et al. January 8, 2	2013-01-08
Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors App 20120196906 - Mjalli; Adnan M.M. ; et al.	2012-08-02
Substituted Imidazo[1,2-a]pyridine Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20120101093 - Mjalli; Adnan M. M. ; et al.	2012-04-26
Substituted Isoquinoline Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20120101125 - Mjalli; Adnan M. M. ; et al.	2012-04-26
Substituted Imidazo[1,2-b]pyridazine Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20110237570 - Mjalli; Adnan M.M. ; et al.	2011-09-29
Substituted Imidazole Derivatives And Methods Of Use Thereof App 20110105578 - Jones; David ; et al.	2011-05-05
Substituted Azole Derivatives, Compositions, and Methods of Use App 20110092553 - Mjalli; Adnan M.M. ; et al.	2011-04-21
Substituted Azole Derivatives as Therapeutic Agents App 20110077399 - Mjalli; Adnan M. M. ; et al.	2011-03-31
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors Grant 7,723,369 - Mjalli , et al. May 25, 2	2010-05-25
Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors App 20100113331 - MJALLI; ADNAN M. M. ; et al.	2010-05-06
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors App 20070191385 - Mjalli; Adnan M.M. ; et al.	2007-08-16
Substituted azole derivatives, compositions, and methods of use App 20050187277 - Mjalli, Adnan M.M. ; et al.	2005-08-25
Heteroaryl-fused nitrogen heterocycles as therapeutic agents Grant 6,933,303 - Mjalli , et al. August 23, 2	2005-08-23
Heteroaryl - fused nitrogen heterocycles as therapeutic agents App 20050096335 - Mjalli, Adnan M. M. ; et al.	2005-05-05
Substituted azole derivatives as therapeutic agents App 20040192743 - Mjalli, Adnan M.M. ; et al.	2004-09-30
Substituted azole derivatives as therapeutic agents App 20040186151 - Mjalli, Adnan M.M. ; et al.	2004-09-23
Heteroaryl - fused nitrogen heterocycles as therapeutic agents App 20040014778 - Mjalli, Adnan M.M. ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.